Panelists discuss the goals of treating atopic dermatitis, focusing on symptom control and quality of life, with treatment differing for children and adults, and emphasize using assessment tools such as Eczema Area and Severity Index (EASI)-75/90, Investigator Global Assessment (IGA), and itch scores alongside patient-reported outcomes to guide decisions while also considering disease severity and the impact of atopic comorbidities in treatment approaches.
Video content above is prompted by the following:
1. What are the goals of treatment for a patient with atopic dermatitis?
a. How do treatment goals differ for atopic dermatitis in the pediatric population compared with adults?
b. How do you leverage standard assessment tools such as EASI-75/90, IGA, and itch scores vs patient- and caregiver-reported outcomes?
2. When considering disease severity and a treatment approach, how do you determine systemic eligibility in a pediatric patient?
3. Does the presentation of atopic comorbidities dictate a treatment approach?
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.